FTC appeal is “demonstrably wrong”, says ViroPharma
Shire ViroPharma is calling for an appeals court to affirm a ruling against the Federal Trade Commission, on the grounds that the agency did not demonstrate the company is, or is about to, violate the law.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10